Lv2
130 积分 2025-05-30 加入
Abstract PO-076: Murine adapted FOLFIRINOX for standard-of-care in KPC mice
1个月前
已完结
Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer
3个月前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
4个月前
已完结
Non-regulated LC–MS/MS bioanalysis in support of early drug development: a Novartis perspective
5个月前
已完结
N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions
5个月前
已关闭
Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration
5个月前
已完结
Metabolism of new drug modalities research advances – 2024 year in review
6个月前
已完结
Drug Targeting Towards the Lymphatics
6个月前
已完结
Drug Targeting Towards the Lymphatics
6个月前
已关闭
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
6个月前
已完结
皖公网安备34019202002308
